COI
BIIB icon

Connable Office Inc’s Biogen BIIB Stock Holding History

Connable Office Inc’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-6,309
Closed -$2.23M – 157
2018
Q3 		$2.23M Sell
6,309
-33
-0.5% -$11.4K 0.43% 54
2018
Q2 		$1.84M Sell
6,342
-15
-0.2% -$4.22K 0.37% 64
2018
Q1 		$1.74M Buy
6,357
+95
+2% +$29.5K 0.34% 66
2017
Q4 		$2M Buy
6,262
+526
+9% +$169K 0.39% 59
2017
Q3 		$1.8M Sell
5,736
-36
-0.6% -$10.7K 0.37% 60
2017
Q2 		$1.57M Buy
+5,772
New +$1.53M 0.34% 62

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Connable Office Inc's BIIB Position: Q4 2018 in Review

Connable Office Inc sold out of Biogen (BIIB) in Q4 2018, closing a stake of 6,309 shares — an estimated $2.23M sold.

Connable Office Inc first reported a position in BIIB in Q2 2017 and held it in 6 quarters. The position peaked at $2.23M in Q3 2018. 1,140 funds tracked by Wall St. Rank hold BIIB as of Q4 2018.

  • Connable Office Inc reported no remaining Biogen position as of Q4 2018 after selling out during the quarter.
  • Connable Office Inc sold 6,309 Biogen shares in Q4 2018, an estimated $2.23M.
  • Connable Office Inc first reported a position in Biogen in Q2 2017 and held it in 6 quarters.
  • Connable Office Inc's Biogen position peaked at $2.23M in Q3 2018.
  • 1,140 funds tracked by Wall St. Rank held Biogen as of Q4 2018.

Based on Connable Office Inc's 13F filing for Q4 2018, filed 12 Feb 2019.